These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2. Buckley LF; Cheng JWM; Desai A J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766 [TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism. Mori J; Oudit GY; Lopaschuk GD Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255 [TBL] [Abstract][Full Text] [Related]
29. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Delpino MV; Quarleri J Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170 [No Abstract] [Full Text] [Related]
31. Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue. Franco R; Lillo A; Rivas-Santisteban R; Rodríguez-Pérez AI; Reyes-Resina I; Labandeira-García JL; Navarro G Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339432 [TBL] [Abstract][Full Text] [Related]
32. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders. Cao X; Song LN; Yang JK Clin Sci (Lond); 2021 Feb; 135(3):535-554. PubMed ID: 33533405 [TBL] [Abstract][Full Text] [Related]
33. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C Front Immunol; 2020; 11():2014. PubMed ID: 32849666 [TBL] [Abstract][Full Text] [Related]
34. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Lazartigues E; Feng Y; Lavoie JL Curr Pharm Des; 2007; 13(12):1231-45. PubMed ID: 17504232 [TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production. Franco R; Rivas-Santisteban R; Serrano-Marín J; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G J Immunol; 2020 Sep; 205(5):1198-1206. PubMed ID: 32680957 [TBL] [Abstract][Full Text] [Related]
36. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760 [No Abstract] [Full Text] [Related]
37. ACE and ACE2 in inflammation: a tale of two enzymes. Gaddam RR; Chambers S; Bhatia M Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157 [TBL] [Abstract][Full Text] [Related]
38. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives. Ribeiro VT; de Souza LC; Simões E Silva AC Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system? Silhol F; Sarlon G; Deharo JC; Vaïsse B Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915 [No Abstract] [Full Text] [Related]
40. Renin-angiotensin system at the heart of COVID-19 pandemic. Alifano M; Alifano P; Forgez P; Iannelli A Biochimie; 2020 Jul; 174():30-33. PubMed ID: 32305506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]